Home › Funds › HAMILTON LANE ADVISORS LLC › HUMA
HAMILTON LANE ADVISORS LLC position in HUMA
HUMACYTE INC · Health Care
HAMILTON LANE ADVISORS LLC reported holding 21,893 shares of HUMA (HUMACYTE INC) in its Q3 2026 13F filing — a position valued at US$11K, representing 0.01% of its reported portfolio and ranking #19 among its reported holdings. HAMILTON LANE ADVISORS LLC has disclosed HUMA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HAMILTON LANE ADVISORS LLC's HUMA position evolved
HAMILTON LANE ADVISORS LLC first disclosed a stake in HUMA in Q3 2023 at 21,893 shares (US$64K). The position peaked in Q3 2024 at 21,893 shares, worth US$119K. Across 12 filings, HAMILTON LANE ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 21,893 shares valued at US$11K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 21.89K | $64.15K | New |
| Q4 2023 | 21.89K | $62.18K | Hold |
| Q1 2024 | 21.89K | $68.09K | Hold |
| Q2 2024 | 21.89K | $105.09K | Hold |
| Q3 2024 | 21.89K | $119.10K | Hold |
| Q1 2025 | 21.89K | $37.33K | New |
| Q2 2025 | 21.89K | $45.76K | Hold |
| Q3 2025 | 21.89K | $38.09K | Hold |
| Q4 2025 | 21.89K | $21.03K | Hold |
| Q1 2026 | 21.89K | $13.28K | Hold |
| Q2 2026 | 21.89K | $17.09K | Hold |
| Q3 2026 | 21.89K | $11.33K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HUMA and 13F data
HUMA (HUMACYTE INC) is a Health Care company. 22 other funds we track also report a position in HUMA — the largest reported positions include GREAT POINT PARTNERS LLC (US$2.9M), Lion Point Capital, LP (US$507K), LuminArx Capital Management LP (US$507K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HUMA
- GREAT POINT PARTNERS LLC 3.75M sh · $2.93M · Q2 2026
- Lion Point Capital, LP 650.00K sh · $507.26K · Q2 2026
- LuminArx Capital Management LP 650.00K sh · $507.26K · Q2 2026
More on HAMILTON LANE ADVISORS LLC
FAQ
How long has HAMILTON LANE ADVISORS LLC held HUMA?
HAMILTON LANE ADVISORS LLC has disclosed HUMA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is HAMILTON LANE ADVISORS LLC's current position in HUMA?
As of Q3 2026, HAMILTON LANE ADVISORS LLC holds 21.89K shares of HUMA (HUMACYTE INC), valued at $11.33K, representing 0.01% of its reported portfolio and ranking #19.
Has HAMILTON LANE ADVISORS LLC been buying or selling HUMA?
In the latest 13F filing (Q3 2026), HAMILTON LANE ADVISORS LLC held unchanged its position in HUMA. The position peaked in Q3 2024 at 21.89K shares.
Which other funds hold HUMA?
Other major institutional holders of HUMA include GREAT POINT PARTNERS LLC, Lion Point Capital, LP, LuminArx Capital Management LP, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.